Clinical Trial Update: An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting efficacy and safety data for Niraparib in men with metastatic castration-resistant prostate cancer and DNA-repair anomalies; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2022-03-08